Elara MD Review
Best for: Buyers who want a single platform for both a semaglutide-range and a tirzepatide-range (GLP-1/GIP) injectable plus adjacent wellness peptides (NAD+, sermorelin, glutathione) and are comfortable with a provider whose compounding/pharmacy transparency is limited. Verify molecule identity, compounding status, and pharmacy sourcing directly before purchase.
Elara MD (elaramd.com) is a weight-loss + wellness telehealth platform offering injectable weekly GLP-1 therapy alongside a peptide/longevity menu (NAD+, sermorelin, glutathione). It markets 'Personalized GLP-1' (semaglutide-range dosing 0.2–2.2 mg/week) at $249–$349/month and 'GLP-1/GIP + B12' (tirzepatide-range dosing 2.0–14.0 mg/week) at $349–$649/month, plus microdosing options. Pricing includes a 30-day medication supply shipped every 30 days, with free 1–4 day shipping when prescribed. Marketed as serving 'over 40 states' (no published list). Governing law is Georgia per the Terms of Use; patients 'have the ability to direct their prescription to any pharmacy of their choosing' (no named pharmacy partner). The site does NOT explicitly name the molecules (semaglutide/tirzepatide), does NOT publish an FDA compounded-medication disclaimer, and does NOT disclose LegitScript certification, a named medical director, or the full state list — so this is a LOW-confidence directory entry pending deeper verification. The compounded nature is inferred (high likelihood) from custom microdosing, B12 co-formulation, the sub-$650 price points, and the peptide menu, not from an explicit on-site 'compounded' label. Live-verified 2026-05-31.
Low confidence · Last verified 2026-05-31 · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Elara MD is a solid telehealth option with balanced features and pricing.
Score Breakdown
Drugs Offered
Elara MD prescribes the following GLP-1 medications. Tap a drug to read our clinical guide with FDA label info, dosing schedules, side effects, and trial data.
Pricing
| Dose | Form | Price/mo |
|---|---|---|
| Personalized GLP-1 (low dose, 0.2 mg/wk) | compounded | $249 |
| Personalized GLP-1 (high dose, up to 2.2 mg/wk) | compounded | $349 |
| GLP-1/GIP + B12 (low dose, 2.0 mg/wk) | compounded | $349 |
| GLP-1/GIP + B12 (high dose, up to 14.0 mg/wk) | compounded | $649 |
✓ Pros
- •Transparent, dose-banded monthly pricing published on-site ($249–$649/mo across GLP-1 and GLP-1/GIP+B12 tiers)
- •Both a semaglutide-range and a tirzepatide-range (dual GLP-1/GIP) option, plus microdosing
- •Medication included in the monthly price with free fast shipping when prescribed
- •Broad reach claimed ('over 40 states')
✗ Cons
- •Molecules not explicitly named on-site (marketed only as 'Personalized GLP-1' / 'GLP-1/GIP + B12') — compounded status is inferred, not stated
- •No FDA compounded-medication disclaimer published — falls short of the WLR transparency bar for 503A platforms
- •No named compounding pharmacy partner (prescriptions are patient-directed)
- •LegitScript certification, named medical director, and full state list NOT disclosed
- •Higher price point than several compounded competitors (e.g., the similarly-named but unrelated Elara Health and Wellness at $183/$267)
Ready to start with Elara MD?
Starting at $249/month. See current pricing and start your free consultation.
Sources & methodology
Our Elara MD review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of May 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Alternatives to Elara MD
Belle Health
Best for: Cost-sensitive patients comfortable with the Feb-2026 FDA warning, wanting flat-rate pricing and dietitian-included support
Editorial score · methodology
Bodybuilding Health+
Best for: fitness-oriented patients who want compounded GLP-1 alongside hormone and performance programs from a 25-year-old established brand
Editorial score · methodology
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Ready to start with Elara MD?
Starting at $249/month. See current pricing and start your free consultation.